Status of umbilical cord blood transplantation in the year 2001
Open Access
- 1 June 2001
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (6) , 428-434
- https://doi.org/10.1136/jcp.54.6.428
Abstract
Umbilical cord blood (UCB) transplantation is limited to small recipients because of the low haemopoietic cell dose. Children from ethnic minority groups may benefit most from cord blood transplantation. Cohort controlled retrospective data indicate that there is significantly less acute and chronic graft versus host disease associated with the transplantation of human major histocompatibility complex (HLA) identical sibling cord blood compared with HLA identical sibling marrow. Controlled data are not yet available to confirm this observation in unrelated donor cord blood transplantation. The difference in leukaemic relapse seen after cord blood compared with bone marrow transplantation is also unknown. Tentative recommendations for the use of umbilical cord blood for transplantation are as follows. Collection is indicated from healthy newborn siblings when urgent transplantation is required for an older child in a family. The haematologist responsible for the older child, with the approval of the family and the obstetric team, should contact the medical director of the nearest cord blood bank to discuss arrangements for the UCB to be collected and HLA typed. Antenatal blood sampling to HLA type the fetus is not recommended. Umbilical cord blood should be considered when allogeneic transplantation is the treatment of choice for a child who does not have an HLA identical sibling, or a well matched unrelated adult volunteer donor. The potential advantages and disadvantages of using an HLA haplotype matched peripheral blood stem cell family donor rather than an unrelated cord blood donation should be discussed. There are no comparative data available as yet. At present, UCB transplantation should only be considered if a suitably matched donation contains at least 2 × 107/kg nucleated cells. Effectively, this means that most adults and larger children are not suitable recipients.Keywords
This publication has 37 references indexed in Scilit:
- Development of a district Cord Blood Bank: a model for cord blood banking in the National Health ServiceBone Marrow Transplantation, 2000
- Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord bloodBone Marrow Transplantation, 2000
- CD34+ cell dose predicts relapse and survival after T‐cell‐depleted HLA‐identical haematopoietic stem cell transplantation (HSCT) for haematological malignanciesBritish Journal of Haematology, 2000
- Umbilical cord blood T lymphocytes are induced to apoptosis after being allo-primed in vitroBone Marrow Transplantation, 1999
- Transplantation of unrelated cord blood cellsBone Marrow Transplantation, 1998
- Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated RecipientsNew England Journal of Medicine, 1996
- Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocolsHuman Molecular Genetics, 1995
- EVIDENCE THAT UMBILICAL CORD BLOOD CONTAINS A HIGHER FREQUENCY OF HLA CLASS II-SPECIFIC ALLOREACTIVE T CELLS THAN ADULT PERIPHERAL BLOODTransplantation, 1992
- Cytokine Stimulation of Multilineage Hematopoiesis from Immature Human Cells Engrafted in SCID MiceScience, 1992
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989